About Us

Ivir Vaccine, Inc. is a biotech company committed to developing therapeutic cancer vaccines. Our mission is to provide cancer patients with safer, more effective vaccines that have fewer side effects, offering them the chance to live longer, healthier, and higher-quality lives.

Founder & CEO

Dr. Weizhou Hou, the founder and CEO of Ivir Vaccine, has been dedicated to developing new cancer drugs for nearly two decades, gaining extensive practical experience in this field. He has worked with companies such as Pfizer, Astellas, Roche, and Sanofi to co-develop cancer drugs using the vaccinia virus as a vector.

Ivir Vaccine Founder & CEO：Weizhou Hou